RIGEL PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $20.0M | $34.0M | $30.4M |
| FY2021 | $20.0M | $30.4M | $18.9M |
| FY2022 | $40.0M | $-13.6M | $24.5M |
| FY2023 | $60.0M | $-28.6M | $32.8M |
| FY2024 | $60.0M | $3.3M | $56.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $20.0M | $34.0M | $30.4M |
| FY2021 | $20.0M | $30.4M | $18.9M |
| FY2022 | $40.0M | $-13.6M | $24.5M |
| FY2023 | $60.0M | $-28.6M | $32.8M |
| FY2024 | $60.0M | $3.3M | $56.7M |